Accelerating Innovation: CAMTech Accelerator Program (CAP)

A virtual one-stop shop for innovator resources, access to variety of experts as well as other entrepreneurs.

The CAMTech Accelerator Program (CAP) is an initiative on the CAMTech Innovation Platform (CIP) that provides CIP users with robust support for early-stage global health technologies focused on improving health outcomes in low- and middle-income countries. In addition to the existing expertise and resources provided through the CIP, each team will receive the following additional support to accelerate the path to commercialization:

  • CAMTech Innovation Award milestone-based funding (up to $50,000 USD) to support prototype/product development, feasibility and design studies and commercialization/scale up efforts.
  • A CAP Coach who will offer project management services to assist entrepreneurial teams in product development and commercialization efforts.
  • Participation in the CAP Cohort, which will help to publicize a team’s innovation and provide a wide range of peer-to-peer engagement opportunities.
  • Guided and customized expert match-making with CAMTech’s extensive global network of partners and collaborators to provide targeted mentorship (including ad hoc on-the-ground services depending on the country) via the CIP.

Learn more about the CAP teams receiving 3-12 months of acceleration support from CAMTech:

RespirAid

Welcome to our newest team to join the CAP! The CAP awarded RespirAid 6 months of acceleration support and $15K USD. Team RespirAid, winners of the CAMTech-X Demo Day, designed an affordable alternative to current manual/hand-held ventilation devices. RespirAid works with existing ventilation bags to ensure safer and more effective care for India’s urban poor.

Jana Care

The CAP awarded Jana Care 8 months of acceleration support and $25K USD. Designing a point-of-care test for HbA1c for greater access in resource-limited settings, Jana Care successfully secured $2.5 million in investment through CAMTech’s network. The Aina device, a mobile blood analyzer, measures glucose, hemoglobin, A1c, creatinine, hemoglobin, lipids and other indicators for diabetes diagnostics. Jana Care uses mobile phones to personalize digital health and to provide real-time updates to physicians, re-inventing care for non-communicable diseases in low- and middle-income countries. After completing usability testing in India, Jana Care is now exploring additional partnerships abroad.

Sanidrop

The CAP awarded Sanidrop 12 months of acceleration support and $25K USD. A company launched under Collard, Inc., Sanidrop is a small production unit for hand sanitizer to reduce transmission of infectious diseases in Uganda. Developed at the CAMTech Uganda Co-Creation Lab at Mbarara University of Science and Technology, Sanidrop increases access to hand sanitizers to kill pathogens at an affordable cost. This gel-based hand sanitizer serves as a conditioning, convenient, cooling, soap free, non-greasy and non-tacky replacement to soap and water if unavailable. Since development, Collard, Inc. established a production lab for Sanidrop, began the regulatory approval stage with the Ugandan government, connected with government-regulated medical stores and is currently working on an agreement to sell Sanidrop nationally in Uganda.

Just Milk

The CAP awarded Just Milk 12 months of acceleration support and $25K USD. A model method of delivering drugs and nutrients to breastfeeding infants to improve reproductive, maternal, neonatal and child health in South Africa. The JustMilk Nipple Shield Delivery System encourages breastfeeding and uses a thin, disposable silicone nipple shield to disperse medication to infants safely and effectively. Currently, Just Milk is organizing a clinical trial with Massachusetts General Hospital to be conducted at the end of 2017 or beginning of 2018.

129

GEMs Boxes

The CAP awarded GEMs Boxes 6 months of acceleration support and $10K USD. In September 2016, CAMTech and the GE Foundation launched an Opioid Epidemic Challenge Summit and Hack-a-thon to organize over 220 global health innovators addressing prevention, diagnosis and treatment of opioid use disorders. GEMs Boxes took home $10K for innovating a life-saving supply kiosk for people suffering opioid overdoses. Since the Opioid Epidemic Challenge Summit and Hack-a-Thon, Mass Challenge accepted GEMs Boxes into the 2017 Class of Startups. The team officially filed IP for their innovation in April 2017 and is in discussions with several large national corporations and police departments across the nation as potential buyers of GEMs Boxes. Recently, the team performed a feasibility/user trial in Cambridge, Massachusetts with the Pro EMS group and volunteers from Brigham and Women’s Hospital. Among 54 participants, 53 successfully used the innovation on dummy mannequins.

gems 2

NovaVeil

The CAP awarded NovaVeil 6 months of acceleration support and $25K CAD. Participating in the Zika Innovation Hack-a-thon in April 2016, CAMTech and Grand Challenges Canada awarded NovaVeil for their clothing design. In partnership with Brazilian superstar designer Allesandra Gold, the team innovated mosquito protective apparel. Additionally, NovaVeil launched a trial production run of treated maternity shirts in partnership with partner Americares.  The shirts have been well received by pregnant women in the poorest sections of El Salvador.

Photo via maternova.

NoraVeil

Near Infrared Spectroscopy (NIRS)

The CAP awarded NIRS 6 months of acceleration support and $25K CAD. The NIRS provides a novel, rapid and high-throughput surveillance technique for the detection of Zika and dengue infections in mosquitoes. Since participating in the Zika Innovation Hack-a-thon with support from Grand Challenges Canada, the team investigated the technique in lab: NIRS operated 40 times faster and 60 times cheaper than PCR for predicting the presence or absence of the viruses in the mosquito vector. In addition, NIRS was 76% accurate for predicting dengue infections in a blind data sets and 86% accurate for detecting the Zika virus on a single cohort of laboratory-reared Aedes aegypti mosquitoes. In collaboration with USAID, NIRS is in validation studies in Brazil.

Photo via Grand Challenges Canada

NIRS

Low Cost Biosensor

The CAP awarded the Low Cost Biosensor 6 months of acceleration support and $25K CAD. Innovated at the Zika Innovation Hack-a-thon in partnership with Grand Challenges Canada, the Low Cost Biosensor operates as a plastic strip that changes color when in contact with saliva samples of the Zika and dengue viruses in patients. Providers can measure saliva samples by coupling the platform with a mobile phone. Moving forward, the team will be working with a group of investors in Curitiba, Brazil who are looking to license the technology in Brazil. The team will also collaborate to finalize a demonstration of feasibility with saliva samples from patients infected with the Zika virus. The demonstration will be performed early next year in Brazil and will include approximately 250 tested strips. Depending on outcomes from the demonstration of feasibility, the team will negotiate a licensing agreement with the investor group.

Photo via Grand Challenges Canada

Low Cost Biosensor

Aedes Home Educational Action Kit (AHEAD)

The CAP awarded the AHEAD Kit 6 months of acceleration support and $25K CAD. The AHEAD Kit offers a multiple mosquito trap design that can be built mainly from recycled materials. Once distributed in schools, students will build the traps and install and maintain them in their homes. The AHEAD Kit gives students an opportunity to show their results on a social media and game-like reporting system. The project combines mosquito population reduction, education, mosquito surveillance and continued improvement of low-cost trap technology. Since participating in the Zika Innovation Hack-a-thon with Grand Challenges Canada, the team is exploring partnerships in Jamaica to test the educational capacity in schools and is performing additional tests in the lab.

Photo via Grand Challenges Canada

AHEAD Kit

Larvicide Automatic Dispenser

The CAP awarded the Larvicide Automatic Dispenser 6 months of acceleration support and $25K CAD. Competing in the Zika Innovation Hack-a-thon with sponsorship from Grand Challenges Canada, LAD is designed to be easily deployed on large tanks and barrels of potable water and dispenses larvicide. Each larvicide inhibits malaria, Zika, dengue and Chikungunya vectors from breeding on these large, still, potable water containers present in many households throughout affected regions. Since the Zika Innovation Hack-a-thon, the team created its first prototype and began work on a second iteration, which would allow for a simpler, cheaper product while maintaining the same features. The team has also made several contacts with Brazilian health officials with whom they are working towards building partnerships. Additionally, the Clinton Global Initiative University awarded LAD $3.5K, Mass Challenge named LAD one of the 128 finalists in 2017 and the team launched a new company, Amelior Technologies.

LAD

LarvaFinder

The CAP awarded LarvaFinder 6 months of acceleration support and $25K CAD. Operating as an add-on device to a smartphone combined with a mobile application, LarvaFinder allows public health agents to reliably detect in real-time the presence of mosquito larvae in any stagnant water body. Awarded support from Grand Challenges Canada during the Zika Innovation Hack-a-thon, LarvaFinder also identifies the specific mosquito species of larvae. The device geo-tags and transmits data to public health agencies in real time, tooling agencies with the information necessary to take action based on neighborhood trends. In January, the team launched LarvaFinder in Panama to test the hardware solution. Recently, the team has identified the Panamanian health agency as a potential first customer, established contact with government funding agencies and approached investor groups in Brazil who are interested in Zika-related technologies.

Larva Finder

*All CAP applicants must first login or sign-up on the CIP.